Template:Chemotherapeutic agents: Difference between revisions
From WikiMD's Wellness Encyclopedia
No edit summary |
en>Jonesey95 m Fix Linter errors related to text color in dark mode; this generally works but may cause problems, in which case revert or try specifying a different CSS value. |
||
| Line 10: | Line 10: | ||
| group1 = Block [[microtubule]] assembly | | group1 = Block [[microtubule]] assembly | ||
| list1 = | | list1 = | ||
* ''[[ | * ''[[Vinca alkaloid]]s'' ([[Vinblastine]]<sup>#</sup> | ||
* [[Vincristine]]<sup>#</sup> | * [[Vincristine]]<sup>#</sup> | ||
* [[Vindesine]] | * [[Vindesine]] | ||
| Line 51: | Line 51: | ||
* [[Fludarabine]]) | * [[Fludarabine]]) | ||
* [[Nelarabine]] | * [[Nelarabine]] | ||
* [[Rabacfosadine]] | |||
* ''[[Thiopurine]]'' ([[Mercaptopurine]]<sup>#</sup> | * ''[[Thiopurine]]'' ([[Mercaptopurine]]<sup>#</sup> | ||
* [[Tioguanine]]<sup>#</sup>) | * [[Tioguanine]]<sup>#</sup>) | ||
| Line 64: | Line 64: | ||
* [[Tegafur]] ([[Tegafur/gimeracil/oteracil|+gimeracil/oteracil]])) | * [[Tegafur]] ([[Tegafur/gimeracil/oteracil|+gimeracil/oteracil]])) | ||
* ''[[DNA polymerase inhibitor]]'' ([[Cytarabine]]<sup>#</sup>) | * ''[[DNA polymerase inhibitor]]'' ([[Cytarabine]]<sup>#</sup> [[Daunorubicin/cytarabine|+daunorubicin]]) | ||
* ''[[Ribonucleotide reductase inhibitor]]'' ([[Gemcitabine]]<sup>#</sup>) | * ''[[Ribonucleotide reductase inhibitor]]'' ([[Gemcitabine]]<sup>#</sup>) | ||
| Line 85: | Line 85: | ||
* [[Camptothecin]] | * [[Camptothecin]] | ||
* [[Cositecan]]<sup>†</sup> | * [[Cositecan]]<sup>†</sup> | ||
* [[Etirinotecan pegol]]<sup>†</sup> | |||
* [[Exatecan]] | * [[Exatecan]] | ||
* [[Gimatecan]] | * [[Gimatecan]] | ||
| Line 102: | Line 103: | ||
* ''[[Anthracycline]]s'' ([[Aclarubicin]] | * ''[[Anthracycline]]s'' ([[Aclarubicin]] | ||
* [[Amrubicin]]<sup>†</sup> | * [[Amrubicin]]<sup>†</sup> | ||
* [[Daunorubicin]]<sup>#</sup> | * [[Daunorubicin]]<sup>#</sup> ([[Daunorubicin/cytarabine|+cytarabine]]) | ||
* [[Doxorubicin]]<sup>#</sup> | * [[Doxorubicin]]<sup>#</sup> | ||
* [[Epirubicin]] | * [[Epirubicin]] | ||
| Line 109: | Line 110: | ||
* [[Valrubicin]] | * [[Valrubicin]] | ||
* [[Zorubicin]]) | * [[Zorubicin]]) | ||
* ''[[Anthraquinone|Anthracenedione]]s'' ([[Mitoxantrone]] | * ''[[Anthraquinone|Anthracenedione]]s'' ([[Losoxantrone]] | ||
* [[Mitoxantrone]] | |||
* [[Pixantrone]]) | * [[Pixantrone]]) | ||
* [[Amsacrine]] | |||
* [[Bisantrene]] | |||
* [[Crisnatol]] | |||
* [[Menogaril]]<sup>§</sup> | |||
}} | }} | ||
| Line 124: | Line 129: | ||
* [[Cyclophosphamide]]<sup>#</sup> ([[Ifosfamide]]<sup>#</sup> | * [[Cyclophosphamide]]<sup>#</sup> ([[Ifosfamide]]<sup>#</sup> | ||
* [[Trofosfamide]]) | * [[Trofosfamide]]) | ||
* [[Chlorambucil]]<sup>#</sup> ([[Melphalan]] | * [[Chlorambucil]]<sup>#</sup> | ||
* [[Prednimustine]] | * [[Melphalan]] ([[Melphalan flufenamide]]) | ||
* [[Prednimustine]] | |||
* [[Uramustine]] | * [[Uramustine]] | ||
| Line 156: | Line 162: | ||
* [[Altretamine]] | * [[Altretamine]] | ||
* ''[[Hydrazine]]s'' ([[Procarbazine]]<sup>#</sup>) | * ''[[Hydrazine]]s'' ([[Procarbazine]]<sup>#</sup>) | ||
* [[Etoglucid]] | |||
* [[Mitobronitol]] | * [[Mitobronitol]] | ||
* [[Pipobroman]] | * [[Pipobroman]] | ||
* ''[[Triazene]]s'' ([[Dacarbazine]]<sup>#</sup> | * ''[[Triazene]]s'' ([[Dacarbazine]]<sup>#</sup> | ||
* [[Mitozolomide]]<sup>§</sup> | |||
* [[Temozolomide]]) | * [[Temozolomide]]) | ||
| group4 = [[Intercalation (biochemistry)|Intercalation]] | | group4 = [[Intercalation (biochemistry)|Intercalation]] | ||
| list4 = | | list4 = | ||
* [[Streptomyces]] ([[ | * [[Streptomyces]] ([[Dactinomycin]]<sup>#</sup> | ||
* [[Bleomycin]]<sup>#</sup> | * [[Bleomycin]]<sup>#</sup> | ||
* [[Mitomycins]] | * [[Mitomycins]] | ||
| Line 175: | Line 183: | ||
| group4 = [[Photosensitizer]]s/[[Photodynamic therapy|PDT]] | | group4 = [[Photosensitizer]]s/[[Photodynamic therapy|PDT]] | ||
| list4 = | | list4 = | ||
* [[Aminolevulinic acid | * [[Aminolevulinic acid]] | ||
* [[Efaproxiral]] | * [[Efaproxiral]] | ||
* [[Methyl aminolevulinate]] | |||
* [[Padeliporfin]] | * [[Padeliporfin]] | ||
* ''[[Porphyrin|Porphyrin derivatives]]'' ([[Porfimer sodium]] | * ''[[Porphyrin|Porphyrin derivatives]]'' ([[Porfimer sodium]] | ||
| Line 197: | Line 206: | ||
** [[Bortezomib]] | ** [[Bortezomib]] | ||
** [[Carfilzomib]] | ** [[Carfilzomib]] | ||
** [[Oprozomib]] | |||
** [[Ixazomib]] | ** [[Ixazomib]] | ||
* ''[[Phosphodiesterase inhibitor|PhI]]'' ([[Anagrelide]]) | * ''[[Phosphodiesterase inhibitor|PhI]]'' ([[Anagrelide]]) | ||
* ''[[IMP dehydrogenase|IMPDI]]'' ([[Tiazofurin]]<sup>§</sup>) | * ''[[IMP dehydrogenase|IMPDI]]'' ([[Tiazofurin]]<sup>§</sup>) | ||
* ''[[Lipoxygenase inhibitor|LI]]'' ([[Masoprocol]]) | * ''[[Lipoxygenase inhibitor|LI]]'' ([[Masoprocol]]) | ||
* ''[[PARP inhibitor]]'' ([[Niraparib]] | * ''[[PARP inhibitor]]'' ([[Fuzuloparib]] | ||
* [[Niraparib]] [[Niraparib/abiraterone acetate|+abiraterone acetate]] | |||
* [[Olaparib]] | * [[Olaparib]] | ||
* [[Rucaparib]]) | * [[Rucaparib]]) | ||
* ''[[Histone deacetylase inhibitor|HDAC]]'' ([[Belinostat]] | * ''[[Histone deacetylase inhibitor|HDAC]]'' ([[Belinostat]] | ||
* [[Entinostat]] | |||
* [[Panobinostat]] | * [[Panobinostat]] | ||
* [[Romidepsin]] | * [[Romidepsin]] | ||
* [[Vorinostat]]) | * [[Vorinostat]]) | ||
* ''[[Phosphoinositide 3-kinase inhibitor|PIKI]]'' ([[Alpelisib]] | * ''[[Phosphoinositide 3-kinase inhibitor|PIKI]] (Pi3K)'' ([[Alpelisib]] | ||
* [[Idelalisib]]) | * [[Copanlisib]]<sup>‡</sup> | ||
* [[Duvelisib]] | |||
* [[Idelalisib]] | |||
* [[Inavolisib]] | |||
* [[Umbralisib]]<sup>‡</sup>) | |||
* ''[[Isocitrate dehydrogenase|IDH]]'' ([[Enasidenib]] | |||
* [[Ivosidenib]] | |||
* [[Olutasidenib]] | |||
* [[Vorasidenib]]) | |||
| group2 = [[Receptor antagonist]]s | | group2 = [[Receptor antagonist]]s | ||
| Line 219: | Line 239: | ||
| group3 = Other/ungrouped | | group3 = Other/ungrouped | ||
| list3 = | | list3 = | ||
* [[ | * [[Adagrasib]] | ||
* [[Aflibercept]] | |||
* [[Arsenic trioxide]] | * [[Arsenic trioxide]] | ||
* ''[[Asparagine|Asparagine depleter]]s'' ([[Asparaginase]]<sup>#</sup>/[[Pegaspargase]]) | * ''[[Asparagine|Asparagine depleter]]s'' ([[Asparaginase]]<sup>#</sup>/[[Pegaspargase]]) | ||
* [[Axicabtagene ciloleucel]] | |||
* [[Belzutifan]] | |||
* [[Bexarotene]] | |||
* [[Brexucabtagene autoleucel]] | |||
* [[Celecoxib]] | * [[Celecoxib]] | ||
* [[Ciltacabtagene autoleucel]] | |||
* [[Demecolcine]] | * [[Demecolcine]] | ||
* [[Denileukin diftitox]] | |||
* [[Eflornithine]] | |||
* [[Elesclomol]]<sup>§</sup> | * [[Elesclomol]]<sup>§</sup> | ||
* [[Elsamitrucin]] | * [[Elsamitrucin]] | ||
* [[Epacadostat]] | |||
* [[Eribulin]] | * [[Eribulin]] | ||
* [[Estramustine phosphate]] | * [[Estramustine phosphate|Estramustine]] | ||
* [[ | * [[Glasdegib]] | ||
* [[Idecabtagene vicleucel]] | |||
* [[Imetelstat]] | |||
* [[Lifileucel]] | |||
* [[Lisocabtagene maraleucel]] | |||
* [[Lonidamine]] | * [[Lonidamine]] | ||
* [[Lucanthone]] | * [[Lucanthone]] | ||
* [[Lurbinectedin]] | |||
* [[Mitoguazone]] | * [[Mitoguazone]] | ||
* [[Mitotane]] | * [[Mitotane]] | ||
* [[Nadofaragene firadenovec]] | |||
* [[Navitoclax]] | |||
* [[Obecabtagene autoleucel]] | |||
* [[Oblimersen]]<sup>†</sup> | * [[Oblimersen]]<sup>†</sup> | ||
* [[Omacetaxine mepesuccinate]] | * [[Omacetaxine mepesuccinate]] | ||
* [[ | * [[Plitidepsin]] | ||
* [[Tabelecleucel]] | |||
* ''[[Retinoid]]s'' ([[Alitretinoin]] | * ''[[Retinoid]]s'' ([[Alitretinoin]] | ||
* [[Tretinoin]]<sup>#</sup>) | * [[Tretinoin]]<sup>#</sup>) | ||
* [[Selinexor]] | |||
* [[Sitimagene ceradenovec]] | |||
* [[Sotorasib]] | |||
* [[Tagraxofusp]] | |||
* [[Talimogene laherparepvec]] | |||
* [[Tazemetostat]] | |||
* [[Tebentafusp]] | |||
* [[Tiazofurine]] | |||
* [[Tigilanol tiglate]] | |||
* [[Tisagenlecleucel]] | |||
* [[Trabectedin]] | |||
* [[Veliparib]] | |||
* [[Venetoclax]] | * [[Venetoclax]] | ||
* [[Verdinexor]] | |||
* [[Vosaroxin]] | |||
}} | }} | ||
| belowstyle = | | belowstyle = padding: 0px; | ||
| below = {{PharmNavFootnote}} | | below = {{PharmNavFootnote}} | ||
}}<noinclude> | }}<noinclude> | ||
{{ | {{Documentation|content= | ||
==Parameters== | |||
{{Collapsible option}} | |||
==See also== | |||
* [[:Category:Medicinal radiochemistry]] | |||
[[Category:Drug templates by ATC]] | [[Category:Drug templates by ATC]] | ||
[[Category:Oncology | [[Category:Oncology navigational boxes]] | ||
</noinclude> | }}</noinclude> | ||
Revision as of 20:08, 4 February 2025
